{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:08:20Z","timestamp":1776308900834,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.rpth.2025.103183","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:36:15Z","timestamp":1757550975000},"page":"103183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing care for patients after major anticoagulant-related bleeding: a narrative review and proposal for a clinical care pathway"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1338-0010","authenticated-orcid":false,"given":"Jurjen F.","family":"Krommenhoek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thijs E.","family":"van Mens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menno V.","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyika D.","family":"Kruyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellis S.","family":"van Etten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten E.","family":"Tushuizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge A.I.P.","family":"Trines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke","family":"van Rein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allard","family":"Aukema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"den Exter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103183_bib1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103183_bib2","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103183_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103183_bib4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103183_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0316796","article-title":"The impact of anticoagulant-related bleeding on quality of life: development of a novel measure based on perspectives from older adults","volume":"20","author":"Parks","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2025.103183_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","article-title":"2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants","volume":"76","author":"Tomaselli","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2025.103183_bib7","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2025.103183_bib8","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103183_bib9","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103183_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.14309\/ajg.0000000000002130","article-title":"Management of patients with acute lower gastrointestinal bleeding: an updated ACG Guideline","volume":"118","author":"Sengupta","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rpth.2025.103183_bib11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/bloodadvances.2020003560","article-title":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry","volume":"5","author":"Bassand","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103183_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4240\/wjgs.v15.i4.723","article-title":"The global epidemiology of upper and lower gastrointestinal bleeding in general population: a systematic review","volume":"15","author":"Saydam","year":"2023","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.rpth.2025.103183_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2019.01.020","article-title":"Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: a systematic review and meta-analysis","volume":"175","author":"Little","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103183_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1742-1241.2011.02827.x","article-title":"Risks related with withholding and resuming anticoagulation in patients with non-variceal upper gastrointestinal bleeding while on warfarin therapy","volume":"66","author":"Lee","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rpth.2025.103183_bib15","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2025.103183_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.amjcard.2013.10.044","article-title":"Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation","volume":"113","author":"Qureshi","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rpth.2025.103183_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ajg.2014.398","article-title":"The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study","volume":"110","author":"Sengupta","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rpth.2025.103183_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(15)30522-9","article-title":"787 Risk of death and thromboembolism in patients that do not resume anticoagulation after an episode of peptic ulcer bleeding [abstract]","volume":"148","author":"Calo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rpth.2025.103183_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1160\/TH16-07-0498","article-title":"Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis","volume":"117","author":"Majeed","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103183_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCG.0000000000000821","article-title":"Resumption of warfarin after hospitalization for lower gastrointestinal bleeding and mortality benefits","volume":"52","author":"Patel","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rpth.2025.103183_bib21","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.cgh.2018.05.005","article-title":"Rebleeding vs thromboembolism after hospitalization for gastrointestinal bleeding in patients on direct oral anticoagulants","volume":"16","author":"Sengupta","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rpth.2025.103183_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cgh.2020.11.029","article-title":"Restarting warfarin vs direct oral anticoagulants after major gastrointestinal bleeding and associated outcomes in atrial fibrillation: a cohort study","volume":"20","author":"Tapaskar","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rpth.2025.103183_bib23","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/jth.15476","article-title":"Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Candeloro","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103183_bib24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/CIRCULATIONAHA.123.066933","article-title":"The efficacy and safety of andexanet alfa in patients with acute gastrointestinal bleeding while taking factor Xa inhibitors: an ANNEXA-4 subanalysis","volume":"149","author":"Siegal","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103183_bib25","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103183_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","article-title":"Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial","volume":"20","author":"Schreuder","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2025.103183_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(25)00333-2","article-title":"Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial","volume":"405","author":"Veltkamp","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2025.103183_bib30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S1474-4422(21)00264-7","article-title":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial","volume":"20","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2025.103183_bib28","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(23)02025-1","article-title":"Anticoagulation in patients with cerebral amyloid angiopathy","volume":"402","author":"Shoamanesh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2025.103183_bib29","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(23)00315-0","volume":"22","author":"Al-Shahi Salman","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2025.103183_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2025.103183_bib32","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","article-title":"Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis","volume":"48","author":"Murthy","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103183_bib33","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood-2024-197928","article-title":"Rapido: results from a UK-wide audit of 2477 patients who received a reversal agent for a direct oral anticoagulant","volume":"144","author":"Buka","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103183_bib34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1182\/asheducation-2016.1.620","article-title":"What to do after the bleed: resuming anticoagulation after major bleeding","volume":"2016","author":"Witt","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2025.103183_bib35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3949\/ccjm.77a.10018","article-title":"Should anticoagulation be resumed after intracerebral hemorrhage?","volume":"77","author":"Goldstein","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.rpth.2025.103183_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2025.103183_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2023.02.011","article-title":"External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease","volume":"260","author":"Castelijns","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.rpth.2025.103183_bib38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.2019001605","article-title":"How I assess and manage the risk of bleeding in patients treated for venous thromboembolism","volume":"135","author":"Klok","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103183_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1183\/09031936.00040714","article-title":"Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review","volume":"45","author":"Klok","year":"2015","journal-title":"Eur Respir J"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2025.103183_bib40","article-title":"External validation of HASBLED and ORBIT bleeding risk scores in Wales-AF population","volume":"44","author":"Torabi","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2025.103183_bib41","doi-asserted-by":"crossref","first-page":"109703","DOI":"10.18632\/oncotarget.19858","article-title":"Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.rpth.2025.103183_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (anticoagulation and risk factors in atrial fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2025.103183_bib43","first-page":"3258","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O\u2019Brien","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2025.103183_bib44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/a-1369-5274","article-title":"Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2021","volume":"53","author":"Gralnek","year":"2021","journal-title":"Endoscopy"},{"key":"10.1016\/j.rpth.2025.103183_bib45","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.593087","article-title":"Optimal timing of resumption of warfarin after intracranial hemorrhage","volume":"41","author":"Majeed","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103183_bib46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","article-title":"Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation","volume":"48","author":"Pennlert","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103183_bib47","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jth.15776","article-title":"Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease","volume":"20","author":"den Exter","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103183_bib48","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/cpt.2369","article-title":"Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study","volume":"110","author":"Gronich","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rpth.2025.103183_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.thromres.2023.03.007","article-title":"Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: a narrative review","volume":"231","author":"van der Horst","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103183_bib50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10654-021-00794-w","article-title":"Prediction or causality? A scoping review of their conflation within current observational research","volume":"36","author":"Ramspek","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rpth.2025.103183_bib51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jth.12874","article-title":"Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial","volume":"13","author":"Westenbrink","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103183_bib52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"Kumbhani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2025.103183_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2023.100158","article-title":"Value of hospital anticoagulation stewardship programme: a systematic review","volume":"14","author":"Silvari","year":"2024","journal-title":"Thromb Update"},{"key":"10.1016\/j.rpth.2025.103183_bib54","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care?","volume":"363","author":"Porter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2025.103183_bib55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jtha.2023.02.015","article-title":"Outcomes of venous thromboembolism care: future directions","volume":"21","author":"de Jong","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103183_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1270","article-title":"Quality of life and depression 3 months after intracerebral hemorrhage","volume":"9","author":"Sallinen","year":"2019","journal-title":"Brain Behav"},{"key":"10.1016\/j.rpth.2025.103183_bib57","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/STROKEAHA.108.538967","article-title":"Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) Trial","volume":"40","author":"Christensen","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103183_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007230","article-title":"TRIGGER investigators. Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial","volume":"5","author":"Campbell","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2025.103183_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006703","article-title":"Impact of spontaneous extracranial bleeding events on health state utility in patients with atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial","volume":"6","author":"Wang","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rpth.2025.103183_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c186","article-title":"The routine use of patient reported outcome measures in healthcare settings","volume":"340","author":"Dawson","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.rpth.2025.103183_bib61","article-title":"Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs","author":"Rotter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2025.103183_bib62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/JMDH.S151196","article-title":"Multidisciplinary approach to the management of pulmonary embolism patients: the pulmonary embolism response team (PERT)","volume":"11","author":"Root","year":"2018","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.rpth.2025.103183_bib63","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11239-021-02512-5","article-title":"Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot study","volume":"53","author":"Benzidia","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2025.103183_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.acvd.2023.11.005","article-title":"Care pathways for patients with cancer-associated thrombosis: from diagnosis to long-term follow-up","volume":"117","author":"Sevestre","year":"2024","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.rpth.2025.103183_bib65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00392-023-02364-4","article-title":"A multidisciplinary pulmonary embolism response team (PERT): first experience from a single center in Germany","volume":"113","author":"Sagoschen","year":"2024","journal-title":"Clin Res Cardiol"}],"updated-by":[{"DOI":"10.1016\/j.rpth.2025.103243","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000}},{"DOI":"10.1016\/j.rpth.2025.103243","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925005072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:47:20Z","timestamp":1767062840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925005072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2475037925005072"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103183","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing care for patients after major anticoagulant-related bleeding: a narrative review and proposal for a clinical care pathway","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103183"}}